Table 1. Baseline patients’ characteristics.
Baseline patients’ characteristics of our population including gender, ALC, AMC, LMR before initiating treatment, R-IPI score, number of R-CHOP cycles received by each patient, and response to R-CHOP (outcome).
ALC: absolute lymphocyte count; AMC: absolute monocyte count; LMR: lymphocyte-to-monocyte ratio; R-IPI: revised International Prognostic Index; R-CHOP: rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone; V.good: very good.
| Gender | ALC (×109/L) | AMC (×109/L) | ALC/AMC | R-IPI score | R-CHOP cycles | Response |
| Male | 2.3912 | 0.5673 | 4.22 | 0 V.good | 6 R-CHOP | Good |
| Female | 1.9782 | 0.8442 | 2.34 | 0 V.good | 6 R-CHOP | Poor |
| Male | 2.875 | 1.087 | 2.64 | 2 Good | 12 R-CHOP | Good |
| Male | 0.5782 | 0.5074 | 1.14 | 3 Poor | 6 R-CHOP | Poor |
| Male | 5.4312 | 0.9052 | 6.00 | 2 Good | 15 R-CHOP | Good |
| Female | 1.5387 | 0.483 | 3.19 | 1 Good | 6 R-CHOP | Good |
| Female | 1.5552 | 0.388 | 4.00 | 2 Good | 6 R-CHOP | Good |
| Female | 0.8554 | 1.0152 | 0.84 | 1 Good | 6 R-CHOP | Poor |
| Male | 2.1329 | 0.5544 | 3.85 | 3 Poor | 8 R-CHOP | Good |
| Female | 1.495 | 0.312 | 4.79 | 3 Poor | 8 R-CHOP | Good |
| Male | 2.7715 | 0.598 | 4.63 | 1 Good | 5 R-CHOP | Good |
| Female | 1.106 | 0.6873 | 1.61 | 0 V.good | 8 R-CHOP | Good |
| Male | 2.5536 | 0.5472 | 4.67 | 3 Poor | 6 R-CHOP | Poor |
| Female | 2.2401 | 0.5764 | 3.89 | 3 Poor | 6 R-CHOP | Good |
| Female | 1.836 | 0.714 | 2.57 | 1 Good | 6 R-CHOP | Good |
| Female | 1.625 | 0.5135 | 3.16 | 2 Good | 8 R-CHOP | Good |
| Male | 1.4529 | 0.609 | 2.39 | 4 Poor | 6 R-CHOP | Poor |
| Female | 2.618 | 0.952 | 2.75 | 0 V.good | 6 R-CHOP | Good |
| Female | 2.178 | 0.99 | 2.20 | 3 Poor | 6 R-CHOP | Poor |
| Female | 0.9984 | 1.0296 | 0.97 | 1 Good | 6 R-CHOP | Poor |
| Male | 1.827 | 1.0875 | 1.68 | 4 Poor | 8 R-CHOP | Poor |
| Male | 1.2994 | 0.6132 | 2.12 | 3 Poor | 6 R-CHOP | Poor |
| Male | 2.914 | 0.589 | 4.95 | 0 V.good | 5 R-CHOP | Good |
| Female | 0.9176 | 0.3689 | 2.49 | 3 Poor | 6 R-CHOP | Poor |
| Female | 1.062 | 0.4995 | 2.13 | 3 Poor | 8 R-CHOP | Poor |
| Male | 1.551 | 0.627 | 2.47 | 1 Good | 6 R-CHOP | Poor |
| Female | 2.3014 | 0.399 | 5.76 | 0 V.good | 5 R-CHOP | Good |
| Female | 1.248 | 0.2592 | 4.81 | 3 Poor | 6 R-CHOP | Good |
| Male | 1.6891 | 1.231 | 1.37 | 2 Good | 8 R-CHOP | Poor |
| Male | 2.7715 | 0.598 | 4.63 | 1 Good | 6 R-CHOP | Good |
| Female | 1.74 | 0.174 | 10.00 | 2 Good | 5 R-CHOP | Good |
| Male | 1.395 | 0.8649 | 1.61 | 3 Poor | 7 R-CHOP | Poor |
| Male | 0.8288 | 0.8029 | 1.03 | 1 Good | 8 R-CHOP | Good |
| Male | 0.5452 | 0.2842 | 1.92 | 2 Good | 8 R-CHOP | Poor |
| Female | 1.184 | 0.4096 | 2.89 | 0 V.good | 6 R-CHOP | Good |
| Male | 2.716 | 0.291 | 9.33 | 0 V.good | 6 R-CHOP | Good |
| Male | 2.178 | 0.891 | 2.44 | 3 Poor | 6 R-CHOP | Poor |
| Female | 2.195 | 1.232 | 1.78 | 1 Good | 8 R-CHOP | Poor |
| Female | 1.2168 | 0.7696 | 1.58 | 1 Good | 6 R-CHOP | Poor |
| Male | 0.909 | 0.303 | 3.00 | 3 Poor | 8 R-CHOP | Good |
| Female | 2.1252 | 0.805 | 2.64 | 2 Good | 7 R-CHOP | Good |
| Male | 1.3034 | 1.1613 | 1.12 | 2 Good | 6 R-CHOP | Poor |